Valid Ghana · FDA Ghana

MINNODERM 2% SOLUTION (Each bottle contains Minoxidil 20mg

Minoxidil

FDA/SD.265-070712 Minoxidil 20mg cardiovascular system INN generic

What it does

Minoxidil is a medication used to promote hair growth in people with certain types of hair loss.

Commonly used for: hair loss (androgenetic alopecia), baldness

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.265-070712
Registration date
2026-07-21
Expiry date
2029-11-01
Status
Valid
Active ingredient
Minoxidil
Dosage form
Minoxidil
Strength
20mg
Pack size
-
Therapeutic class
-
ATC class (WHO)
C02DC - Pyrimidine derivatives
RxNorm RxCUI
6984
Manufacturer / MAH
Brookes Pvt Pharma Ltd
Applicant / LTR
HEALTH TECH PHARMA
Country of origin
PAKISTAN
Manufacturer location
58 & 59, Sector، 15 Main Korangi Industrial Local Rd, Sector 15 Korangi Industrial Area, Karachi, 74900, Pakistan

Source: Food and Drugs Authority · fetched 2026-09-01 04:00:29 · updated 2026-09-18 04:00:05

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Minoxidil is a medication used to promote hair growth in people with certain types of hair loss.

What it treats

  • hair loss (androgenetic alopecia)
  • baldness

How it works

Minoxidil works by increasing blood flow to the hair follicles, which helps stimulate hair growth.

Who it's for

Minoxidil is for adults experiencing hair thinning or baldness.

Cautions

  • • Avoid using with other medications that lower blood pressure.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Minoxidil

BNF-referenced

Minoxidil is a potent vasodilator primarily used for the treatment of androgenetic alopecia (male and female pattern hair loss) and hypertension. It acts by relaxing the smooth muscle in blood vessels, leading to vasodilation and increased blood flow. Topical formulations are applied to the scalp for hair regrowth, while oral forms are used in severe cases of hypertension.

Indications

  • Androgenetic alopecia
  • Severe hypertension

Dosage

Children: For children, application for scalp conditions should be as required, but specific dosing guidelines for minoxidil in children should be referred to in the BNF for Children.

Adults: For androgenetic alopecia, apply 1 mL to the affected areas of the scalp twice daily. For hypertension, refer to specific dosing guidelines in the BNF.

Mechanism of action

Minoxidil acts as a potassium channel opener, which leads to hyperpolarization of the cell membrane and relaxation of vascular smooth muscle. This results in vasodilation and a decrease in blood pressure. The precise mechanism for its hair growth promoting effects is not fully understood, but it is believed to enhance hair follicle size and prolong the anagen phase of hair growth.

Pharmacodynamics

Minoxidil’s vasodilatory effects lead to a reduction in peripheral vascular resistance and lower blood pressure. For hair growth, the drug appears to increase the size of hair follicles, improve blood flow to the scalp, and stimulate hair follicle cells. These effects contribute to visible improvements in hair density and thickness in patients with androgenetic alopecia.

Pharmacokinetics

Minoxidil is well-absorbed when applied topically, with a bioavailability of approximately 1.5% to 3% for the scalp application. After absorption, minoxidil is extensively metabolized in the liver, primarily to its active sulfate form. It has a half-life of about 4.2 hours and is primarily excreted in the urine. Its effects on blood pressure and hair growth are dose-dependent.

Contra-indications

  • History of hypersensitivity to minoxidil or any of the excipients
  • Use in patients with pheochromocytoma
  • Use in patients with a history of angioedema

Adverse effects

  • Hypertrichosis
  • Headache
  • Dizziness
  • Edema
  • Tachycardia
  • Palpitations
  • Skin irritation
  • Flushing
  • Chest pain

Interactions

  • Caution when used with other antihypertensive agents as it may potentiate their effects
  • Non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the antihypertensive effect
  • Use with caution in combination with vasodilators

Precautions

  • Monitor patients for signs of fluid retention and adjust dosage accordingly
  • Use with caution in patients with cardiovascular disease
  • Discontinue if unexpected weight gain or peripheral edema occurs
  • Avoid use in patients with renal impairment

Pregnancy

Manufacturer advises avoiding use during pregnancy due to potential risk to the fetus.

Breast-feeding

Minoxidil is excreted in breast milk; manufacturer advises avoiding use during breastfeeding.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • Topical solution: 2% and 5% concentrations for scalp application
  • Topical foam: 5% concentration for scalp application
BNF 85 (British National Formulary) p.216 BNF 85 (British National Formulary) p.1417 BNF for Children 2019-2020 p.141 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: Minoxidil

PubChem CID 4201

Molecular formula: C9H15N5O

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.